Leap Therapeutics Inc. buy Rodman & Renshaw
Start price
28.06.24
/
50%
€1.64
Target price
28.06.25
€7.47
Performance (%)
3.66%
Price
27.06.24
€1.65
Summary
This prediction is currently active. With a performance of 3.66%, the BUY prediction by Rodman___Renshaw for Leap Therapeutics Inc. is trending in the right direction. This prediction currently runs until 28.06.25. The prediction end date can be changed by Rodman___Renshaw at any time. Rodman___Renshaw has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Leap Therapeutics Inc. | 3.66% |
| iShares Core DAX® | -0.145% |
| iShares Nasdaq 100 | 1.296% |
| iShares Nikkei 225® | 1.282% |
| iShares S&P 500 | 0.442% |
Comments by Rodman___Renshaw for this prediction
In the thread Leap Therapeutics Inc diskutieren
Leap Therapeutics, Inc. (NASDAQ: LPTX) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $8.00 price target on the stock.
Ratings data for LPTX provided by MarketBeat